Kingworld Medicines Group Limited

HKEX
1110
Stock
Yield per half year: +30.95%
Dividend yield: 5.63%
Sector: Healthcare

Kingworld Medicines Group Limited

0.6100.6100.5670.5670.5240.5240.4810.4810.4380.4380.3950.395Aug '24Aug '24Sep '24Sep '24Oct '24Oct '24Nov '24Nov '24Dec '24Dec '2420252025Feb '25Feb '25Mar '25Mar '25Apr '25Apr '25May '25May '25Jun '25Jun '25Jul '25Jul '25

Underestimation

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
P/E
10/10
6.34 37.2 -82.97% 17.05 -62.83%
P/S 0.2481 4.03 -93.84%
P/BV 0.3732 1.93 -80.71%
P/FCF 3.94 -10.12 -138.97%
Ev/Ebitda 4.52 2.91 55.35%
Ev/S 0.3917 7.34 -94.66%
Ev/FCF 4.39 -11 -139.88%
E/P 0.1113 0.0327 239.87%

Efficiency

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Ebitda margin
4/10
11.13 1.46 662.49% 10.26 +8.51%
ROE 6.6 3.98 66.07%
ROA 3.02 2.89 4.54%
ROIC 0 0 0%
ROS 3.92 10.86 -63.91%
ROCE 0 0.1527 -100%

Debt

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Debt/Ebitda
4/10
3.28 0.3827 757.63% 2.76 +19.08%
Nеt Debt/Ebitda 1.29 -0.2202 -685.82%
Debt/Ratio 0.2738 0.132 107.41%
Debt/Equity 1.01 0.6875 46.38%
Debt/Net Income 9.33 2.61 257.69%

Dividends

Parameter Grade Value Sector average Difference with sector, % Average for 5 years Difference from average, %
Dividend yield
10/10
5.63 4.32 30.46% 3.83 +47.11%
Number of years of dividend growth 3 1.23 144.07%
DSI 0.8571 0.5482 56.36%
Average dividend growth -4.64 -2.77 67.24%
Average percentage for 5 years 3.83 4.29 -10.75%
Average percentage for payments 47.55 34.1 39.45%
Difference from average difference in sector 1.31

Growth impulse

Parameter Grade Value Sector average Difference with sector, %
Growth impulse Revenue in 5 years
6/10
42.35 -94.75 -144.7%
Growth impulse Ebitda in 5 years 108.74 -45.56 -338.67%
Growth impulse Net Income in 5 years 254.7 -111.86 -327.7%
Growth impulse FCF in 5 years -16.65 -138.06 -87.94%
Growth impulse EPS in 5 years 198.03 -139.77 -241.68%
IP Score
6.24/10

Similar companies

Hangzhou Tigermed Consulting Co., Ltd

WuXi Biologics (Cayman) Inc.

CSPC Pharmaceutical Group Limited

WuXi AppTec Co., Ltd.

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription